Audit 403060

FY End
2025-12-31
Total Expended
$6.83M
Findings
11
Programs
7
Year: 2025 Accepted: 2026-06-04
Auditor: COHNREZNICK LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
1216581 2025-001 Material Weakness Yes AB
1216582 2025-001 Material Weakness Yes AB
1216583 2025-001 Material Weakness Yes AB
1216584 2025-001 Material Weakness Yes AB
1216585 2025-001 Material Weakness Yes AB
1216586 2025-001 Material Weakness Yes AB
1216587 2025-001 Material Weakness Yes AB
1216588 2025-001 Material Weakness Yes AB
1216589 2025-001 Material Weakness Yes AB
1216590 2025-001 Material Weakness Yes AB
1216591 2025-001 Material Weakness Yes AB

Programs

ALN Program Spent Major Findings
11.619 ARRANGEMENTS FOR INTERDISCIPLINARY RESEARCH INFRASTRUCTURE $587,711 Yes 1
47.074 BIOLOGICAL SCIENCES $137,670 Yes 1
81.087 RENEWABLE ENERGY RESEARCH AND DEVELOPMENT $49,702 Yes 1
47.041 ENGINEERING $49,500 Yes 1
81.089 FOSSIL ENERGY RESEARCH AND DEVELOPMENT $32,597 Yes 1
81.086 CONSERVATION RESEARCH AND DEVELOPMENT $15,625 Yes 1
81.049 OFFICE OF SCIENCE FINANCIAL ASSISTANCE PROGRAM $15,000 Yes 1

Contacts

Name Title Type
KLPNCLPDAS45 Barbara Valentine Auditee
6464951350 Joseph A. Arnone Auditor
No contacts on file

Notes to SEFA

The accompanying schedule of expenditures of federal awards (the “Schedule”) includes the federal award activity of American Institute of Chemical Engineers (“AIChE”) for the year ended December 31, 2025. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (“Uniform Guidance”). Because the Schedule presents only a selected portion of the operations of AIChE, it is not intended to and does not present the financial position, changes in net assets or cash flows of AIChE.
Expenditures reported on the Schedule are reported on the accrual basis of accounting except for amounts passed through to subrecipients which are reported when cash is disbursed. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or limited as to reimbursement.
AIChE has elected not to use the de minimis indirect cost rate as allowed under the Uniform Guidance.

Finding Details

Criteria Management is responsible for establishing and maintaining effective internal control over financial reporting, including controls to ensure payroll transactions are properly authorized and supported. Per 2 CFR, Part 200.430(g), payroll charges must be supported by records and systems of internal controls that ensure accuracy, allowability, and proper cost allocation. Condition AIChE did not consistently maintain documented evidence of management approval for employee pay rate changes. While pay rate changes were entered into the payroll system and reflected in payroll records, documentation demonstrating formal approval was not retained in certain instances. Cause Approved pay rate documentation was not consistently retained in payroll records. Effect or Potential Effect The lack of approved pay rate documentation increases the risk of unauthorized salary adjustments and improper payroll expenditures and could result in unallowable costs being charged and non-compliance with grant requirements. Questioned Costs None. Context For 6 of 25 payroll samples, pay rate forms with documented approval were not available. Identification as a Repeat Finding This finding is not a repeat finding. Recommendation Management should implement procedures to ensure that documented approval of pay rate changes is consistently retained. Views of Responsible Officials Management will formally document the CEO and CFO approval of all pay rate changes. Although reviews were performed in 2025, formal approval documentation was not maintained.